Vioxx
Celebrex
Bextra
COX-2 Inhibitors
Crestor
Neurontin
Zyprexa
Ephedra
Strattera
Remicade
Accutane
Serzone
Serevent
Tamoxifen
Baycol
Fen Phen
Rezulin
Meridia
PPA
Propulsid
Avara
Permax
Anti-Depressants
OxyContin
Tysabri
Pemoline
 
Guidant Defibrillators
Guidant Ancure Device
Sulzer Hip Replacement
Contraceptive Devices
Breast Implants
 
Welding Rods
Asbestos
Mesothelioma
Lead Poisoning
Silica
 
Cerebral Palsy
Erb's Palsy
Birth Injury
Surgical Mistake
Cancer Misdiagnosis
Nursing Home Negligence
Hospital Negligence
 
Car Accidents
Plane Accidents
Boat Accidents
Bus Accidents
Motorcycle Acc
Brain Injury
Spinal Cord Injury
Dodge Truck and SUV Recall
 
Insurance Bad Faith
Slip and Fall
Dog Bite Injury
Inadequate Security
Recall Forum
Consumer Pro
Sexual Abuse
Product Liability
General Inquiries

Guidant Ancure Device Information

Recently, it is a matter of grave concern that FDA has registered a number of complaints against the Guidant Corp Endovascular Technologies for manufacturing low quality Ancure grafting device. The company has been sued by FDA for manufacturing such risky devices which have already done a lot of damage to the patients. In 2003, the company made an official declaration in a news release that the company would stop making the aortic grafting device. The aorta is the vital blood vessel which comes from the heart. As per the recent survey, 12 incidents of death of the patients have been unofficially declared after undergoing the Ancure grafting.

In fact, doctors have been facing the major problem to handle these defective devices at the time of implantation of these apparatuses into the body for the accurate Ancure grafting process. Depending on the foundation of the powerful evidence and facts given by the federal court, 2600 Ancure grafting devices were sold and all these were defective and substandard. An estimated 18000 patients have been so far offered these Ancure devices. The complication ratio is 1:3 on the total number of patients. Many patients were sent to intensive care unit for emergency operations as their condition was serious after the Ancure device being implanted into their bodies.

There are myriad risk factors which patients will face after the implantation of this apparatus inside the body. This equipment can be broken into small splinters in the body. This is one of the major problems at the time of utilizing this sophisticated device. However, in 2002 Ancure Endograft device was removed from the market as this equipment brought lot of risks and damage to the health of patients. FDA has finally ordered Endo Vascular Technology which is the sister branch of Guidant to appoint an autonomous monitoring agency or organization to keep well track of the latest development in the matter of providing the authentic information to the FDA officials regarding the repairing of all defective Ancure Endograft devices. Finally, if a patient suffers from the physical wound or injury due to the implantation of this device, he must knock at the door of the solicitors firm to contact an efficient lawyer to claim the compensation from the company. The attorney will make a probe to find out the accused person who is responsible for the supply of the faulty Endograft appliance. However, people should not waste time in filing the lawsuit as there is Statute of Limitation. Within the timeframe of one year, lawsuit should be registered in the court to come to the financial settlement with the company.

 



     The EndoVascular stent graft device, known as the "Ancure graft," is used to strengthen the aorta, the main blood vessel stemming from the heart, as it passes through the abdomen. For example, the device is used to treat an abdominal aortic aneurysm, a potentially life-threatening condition. According to one report, during the implant procedure, the equipment used to insert the Ancure graft could become lodged. In other circumstances, the equipment would break apart into pieces before being removed.

     President and CEO of Guidant Corp, Ronald Dollens, apologized for the improper and regrettable steps that were taken by EndoVascular Technologies.




Please share your opinion with us.
Your name:
Your email:
How dangerious do you think this is?:
Write a review for this product:

  Copyright 2009 LawsuitResources.com